Back to Search
Start Over
Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis.
- Source :
- Frontiers in Oncology; 8/26/2022, Vol. 12, p1-3, 3p
- Publication Year :
- 2022
- Subjects :
- PROGRESSION-free survival
OVERALL survival
LUNG cancer
CHEMORADIOTHERAPY
Subjects
Details
- Language :
- English
- ISSN :
- 2234943X
- Volume :
- 12
- Database :
- Complementary Index
- Journal :
- Frontiers in Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159227758
- Full Text :
- https://doi.org/10.3389/fonc.2022.1007862